Public-registry site landscape for NCT04826185, a Non-obstructive Hypertrophic Cardiomyopathy study sponsored by Imbria Pharmaceuticals, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04826185 (registry record) |
| Sponsor | Imbria Pharmaceuticals, Inc. |
| Condition(s) | Non-obstructive Hypertrophic Cardiomyopathy |
| Phase | PHASE2 |
| Listed sites | 14 |
| Site countries | United States, United Kingdom |
Eichor generates a preliminary site-risk snapshot for NCT04826185 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →